Citation Impact
Citing Papers
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Stress and Depression
2004 Standout
The search for determinants of chronic depression: a review of six factors
2002
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder
2000
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
2002
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection
1988 StandoutNature
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity
2000
Decreased Serotonin 5-HT2A Receptor-Stimulated Phosphoinositide Signaling in Fibroblasts from Melancholic Depressed Patients
2004
Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder
2014
New concepts in antimalarial use and mode of action in dermatology
2007
Higher Expression of Serotonin 5-HT2A Receptors in the Postmortem Brains of Teenage Suicide Victims
2002
Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims
1999
Suicide and Suicidal Behavior
2008 Standout
Pharmacokinetics of two Alternative Dosage Forms for Cyclosporine: Liposomes and Intralipid
1990
Three‐Dimensional Reconstruction of Human α2‐Macroglobulin and Refinement of the Localization of Thiol Ester Bonds with Monomaleimido Nanogolda
1994 StandoutNobel
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
A Membrane Transport Defect Leads to a Rapid Attenuation of Translation Initiation in Saccharomyces cerevisiae
2004
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims
2000
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Why is depression bad for the failing heart? a review of the mechanistic relationship between depression and heart failure
2004
Psychedelics
2016 Standout
Solid lipid nanoparticles Production, characterization and applications
2001 Standout
Rab GTPases as coordinators of vesicle traffic
2009 Standout
Adolescent suicide and suicidal behavior
2006 Standout
Altered Serotonin Function in Suicide
1997
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Possible involvement of alpha‐2A adrenergic receptors in attention deficit hyperactivity disorder: Radioligand binding and polymorphism studies
2006
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?
2017
Depression in Heart Failure
2006 Standout
The current status of the platelet 5-HT2A receptor in depression
2000
Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
2005
The anti-inflammatory effects and the inhibition of neutrophil responsiveness by Barleria lupulina and Clinacanthus nutans extracts
2007 Standout
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
2008
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
Neurobiology of Depression
2002 Standout
Gene–environment interaction analysis of serotonin system markers with adolescent depression
2004
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Inhibition of Rab5a Exchange Activity Is a Key Step for Listeria monocytogenes Survival
2005
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
2003 Standout
Major Depressive Disorder
2008 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists
2001
Decrease of the platelet 5‐HT2A receptor function by long‐term imipramine treatment in endogenous depression
2004
Liposomes as nanomedical devices
2015 Standout
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
The interpersonal theory of suicide.
2010 Standout
Designing dendrimers for biological applications
2005 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
1984 StandoutNobel
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Fluoxetine versus other types of pharmacotherapy for depression
2013
Avl9p, a Member of a Novel Protein Superfamily, Functions in the Late Secretory Pathway
2007 StandoutNobel
H-2 Mutations: Their Genetics and Effect on Immune Functions
1978
Neurotrophins and depression
1999
Mechanism of selective killing by dilinoleoylglycerol of cells transformed by the E1A gene of adenovirus type 12.
1989
Recent Advances in Histocompatibility Immunogenetics
1979 StandoutNobel
Paroxetine versus other anti-depressive agents for depression
2014
Detection, Pathogenesis, and Prevention of Damage to Human Granulocytes Caused by Interaction with Nylon Wool Fiber
1977
Lipophilic drug derivatives in liposomes
1998
Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions
2006
Hormonal Control of Lysosomal Enzyme Release from Human Neutrophils: Elevation of Cyclic Nucleotide Levels by Autonomic Neurohormones
1974 StandoutNobel
[44] Leukocyte Elastase
1981
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Depression and ischemic heart disease
2000
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Cross-reactivity patterns of vaccinia-specific cytotoxic T lymphocytes from H-2K b mutants
1983 StandoutNobel
Hormonal Control of Neutrophil Lysosomal Enzyme Release: Effect of Epinephrine on Adenosine 3′,5′-Monophosphate
1974 StandoutScienceNobel
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE FROM HUMAN NEUTROPHILS
1974 StandoutNobel
The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism
1973
Regulation of lysosomal enzyme secretion: Role in inflammation
1974 StandoutNobel
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
Industry sponsorship and research outcome
2017 Standout
Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow Transplants
1978 StandoutNobel
Hallucinogens
2004 Standout
Molecular Genetics of Attention-Deficit/Hyperactivity Disorder
2005 Standout
Breakdown of noncollagenous chondromucoprotein matrix by leukocyte lysosome granule lysates from guinea pig, rabbit, and human
1973 StandoutNobel
Works of Jerzy Chudzik being referenced
Metabolic fate of liposomal phosphatidylinositol in murine tumor cells: implications for the mechanism of tumor cell cytotoxicity.
1985
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment
1997
Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder
1997
Aggregation of unilamellar lecithin liposomes induced by cyclosporin
1986
Effect of chlorpromazine associated with liposomes on the biosynthesis of acidic lipids in subcellular membranes
1986
Effect of chlorpromazine on the synthesis, hydrolysis, and transfer of microsomal cytidine liponucleotides and mitochondrial polyglycerophosphatides
1987
Substrate specificity and modifications of the active centre of elastase-like neutral proteinases from horse blood leucocytes
1976
Co-encapsulation of cyclosporin and insulin by liposomes
1986
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
1995
Platelet serotonin measures in primary dysthymia
1994
The effects of heterologous antisera to soluble proteins from horse leucocyte granules and rat liver mitochondrial-lysosomal fraction on the activity of some lysosomal hydrolases in vitro.
1974
Encapsulation of cyclosporine by phosphatidylinositol-cholesterol liposomes.
1986
The effects of basic substances and acidic ionophores on the digestion of exogenous and endogenous proteins in mouse peritoneal macrophages.
1986
The occurrence of common inhibitors of trypsin and of leucocyte neutral proteinase in human serum
1972